Pharmacological analysis of a dopamine D2Short:Gαo fusion protein expressed in Sf9 cells

FEBS Letters

Volumn 545, Issue 2-3, 2003, Pages 155-160

  Gazi, Lucien ^a   Wurch, Thierry ^b   Lopéz Giménez, Juan F ^a   Pauwels, Petrus J ^b   Strange, Philip G ^a  

^a UNIVERSITY OF READING   (United Kingdom)

^b INSTITUT DE RECHERCHE PIERRE FABRE   (France)

Author keywords

Baculovirus; D2 dopamine receptor; Fusion protein; G protein coupled receptor; 35S Guanosine 5 O (3 thio)triphosphate binding; 3H Spiperone binding

Indexed keywords

10,11 DIHYDROXY N,N PROPYLNORAPOMORPHINE; DOPAMINE; DOPAMINE 2 RECEPTOR; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); GUANOSINE TRIPHOSPHATE; HYBRID PROTEIN; MORPHINE DERIVATIVE; SPIPERONE; SULPIRIDE; UNCLASSIFIED DRUG; ZIPRASIDONE;

ARTICLE; BACULOVIRUS; BINDING AFFINITY; BINDING SITE; CELL CULTURE; DATA ANALYSIS; DRUG PROTEIN BINDING; INSECT CELL; LIGAND BINDING; MODEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

UNIDENTIFIED BACULOVIRUS;

EID: 0037864223     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(03)00520-9     Document Type: Article

References (30)

1. Hoyer D., Boddeke H.W. Trends Pharmacol. Sci. 14:1993;270-275.
2. Kenakin, T. (1997) Pharmacological Analysis of Drug-Receptor interaction, Lippincott-Raven, Philadelphia, PA.
3. Wenzel-Seifert K., Seifert R. Mol. Pharmacol. 58:2000;954-966.
4. Pauwels P.J. Biochem. Pharmacol. 60:2000;1743-1750.
5. Wurch T., Pauwels P.J. J. Pharmacol. Toxicol. Methods. 45:2001;3-16.
6. Milligan G. Trends Pharmacol. Sci. 21:2000;24-28.
7. Seifert R., Wenzel-Seifert K., Kobilka B.K. Trends Pharmacol. Sci. 20:1999;383-389.
8. Gazi, L. and Strange, P.G. (2002) in: Dopamine Receptors (Pangolos, M. and Davies, C., Eds.), pp. 264-285, Oxford University Press, Oxford.
9. Grünewald S., Reiländer H., Michel H. Biochemistry. 35:1996;15162-15173.
10. Liu Y.F., Jacobs K.H., Rasenick M.M., Albert P.R. J. Biol. Chem. 269:1994;13880-13886.
11. Ghahremani M.H., Cheng P.H., Lembo P.M.C., Albert P.R. J. Biol. Chem. 274:1999;9238-9245.
12. Guiramand J., Montmayeur J.-P., Ceraline J., Bhatia M., Borreli E. J. Biol. Chem. 270:1995;7354-7358.
13. Cordeaux Y., Nickolls S.A., Flood L.A., Graber S.G., Strange P.G. J. Biol. Chem. 276:2001;28667-28675.
14. Gazi L., Nickolls S.A., Strange P.G. Br. J. Pharmacol. 138:2003;775-786.
15. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. J. Biol. Chem. 193:1951;265-275.
16. Cheng Y.C., Prusoff W.H. Biochem. Pharmacol. 22:1973;2099-3108.
17. Gardner B., Hall D.A., Strange P.G. Br. J. Pharmacol. 118:1996;1544-1550.
18. Seifert R., Lee T.W., Lam V.T., Kobilka B.K. Eur. J. Biochem. 255:1999;369-382.
19. Burt A.R., Sautel M., Wilson M.A., Rees S., Wise A., Milligan G. J. Biol. Chem. 273:1998;10367-10375.
20. Sautel M., Milligan G. FEBS Lett. 436:1998;46-50.
21. Bevan N., Palmer T., Drmota T., Wise A., Coote J., Milligan G., Rees S. FEBS Lett. 462:1999;61-65.
22. Hall D.A., Strange P.G. Br. J. Pharmacol. 121:1997;731-736.
23. Pauwels P.J., Koek W. Naunyn Schmiedebergs Arch. Pharmacol. 365:2002;82-85.
24. Pauwels P.J., Tardif S., Colpaert F.C. Biochem. Pharmacol. 62:2001;723-732.
25. Wurch T., Boutenet-Robinet E.A., Palmier C., Colpaert F.C., Pauwels P.J. J. Pharmacol. Exp. Ther. 304:2003;380-390.
26. Gettys T.W., Sheriff-Carter K., Moomaw J., Taylor I.L., Raymond J.R. Anal. Biochem. 220:1994;82-91.
27. Raymond J.R., Olsen C.L., Gettys T.W. Biochemistry. 32:1993;11064-11073.
28. Small K.M., Forbes S.L., Rahman F.F., Liggett S.B. Biochemistry. 39:2000;2815-2821.
29. Kenakin T. Trends Pharmacol. Sci. 23:2002;275-280.
30. Jiang M., Spicher K., Boulay G., Wang Y., Birnbaumer L. Proc. Natl. Acad. Sci. USA. 98:2001;3577-3582.